This CME program will highlight recent advances in S1P-based therapeutics for the treatment of patients with multiple sclerosis. The expert faculty, Dr. Clyde Markowitz, will first review the pharmacologic characteristics of all S1P-based therapies to aid in clinical decision making for the early intervention of patients diagnosed with multiple sclerosis (MS). Following, he will discuss long term efficacy and safety data for S1P therapeutics, including impact on physical and cognitive preservation. To conclude, Dr. Markowitz will analyze strategies to update current treatment plans and applied shared decision making to effectively integrate S1P-based therapies into the management and treatment of patients with MS.
MS specialists, other neurologists, and other healthcare professionals involved in the management of patients with multiple sclerosis
Review the various pharmacologic characteristics of all S1P-based therapies to aid in clinical decision making for the early intervention of patients diagnosed with MS.
Analyze longer term efficacy and safety data for S1P therapeutics including impact on physical and cognitive preservation.
Evaluate strategies to update current treatment plans and applied shared decision making to effectively integrate S1P-based therapies in the management of patients with MS.
It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships relating to the topics of this educational activity. Any relevant financial relationships are mitigated via a content review by planning committee members and faculty with no relevant financial relationships.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
| Faculty | Relationship Identified With: |
| Clyde Markowitz, MD | Consultant/Advisor: Alexion Pharmaceuticals, Inc.; ANI; Banner Life Sciences; Biogen; Bristol Myers Squibb; Cycle Pharmaceuticals Limited; EMD Serono; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Sanofi; Horizon Therapeutics plc; Janssen Pharmaceuticals, Inc.; Novartis AG; Teva Pharmaceutical Industries Ltd; TG Therapeutics, Inc. |
Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC; Chelsey Simonds and Nicole McMenamin hereby state that they or their spouse/life partner do not have any relevant financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AcademicCME designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditsTM.
Learners should only claim credit commensurate with the extent of their participation.
This activity has been supported by an independent educational grant from Bristol Myers Squibb.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Bristol Myers Squibb do not recommend the use of any agent outside of the labeled indications.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
In order to claim credit, participants must complete the following:
For all CE inquiries or special needs, please contact admin@academiccme.com.
811 S. Orleans Ave. Tampa, Fl 33606
